Copy number and gene expression alterations in radiation-induced papillary thyroid carcinoma from chernobyl pediatric patients

Thyroid

Volumn 20, Issue 5, 2010, Pages 475-487

  Stein, Leighton ^a   Rothschild, Jenniffer ^a   Luce, Jesse ^a   Cowell, John K ^b   Thomas, Geraldine ^c   Bogdanova, Tatania I ^d   Tronko, Mycola D ^d   Hawthorn, Lesleyann ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d V P Komisarenko Institute of Endocrinology and Metabolism of the Ukraine Academy of Medical Sciences   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CHERNOBYL ACCIDENT; CHROMOSOME 12Q; CHROMOSOME 13Q; CHROMOSOME 16P; CHROMOSOME 1P; CHROMOSOME 21Q; CHROMOSOME 22Q; CHROMOSOME 5P; CHROMOSOME 9Q; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE LOCATION; GENE MAPPING; GENE NUMBER; HIGH THROUGHPUT SCREENING; HUMAN; MALE; MUTATION; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION INJURY; THYROID PAPILLARY CARCINOMA;

CARCINOMA, PAPILLARY; CHERNOBYL NUCLEAR ACCIDENT; CHILD; DNA; FEMALE; GENE DELETION; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROZYGOTE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; NEOPLASMS, RADIATION-INDUCED; POLYMORPHISM, SINGLE NUCLEOTIDE; PRINCIPAL COMPONENT ANALYSIS; RNA; THYROID NEOPLASMS; UKRAINE;

EID: 77952381657     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0008     Document Type: Article

References (59)

1. Acharya S, Sarafoglou K, LaQuaglia M, Lindsley S, Gerald W, Wollner N, Tan C, Sklar C 2003 Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer 97:2397-2403.
2. Inskip PD 2001 Thyroid cancer after radiotherapy for childhood cancer. Med Pediatr Oncol 36:568-573.
3. Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, Berkow RL, Hammond S, Neglia JP, Meadows AT, Sklar CA, Robison LL, Inskip PD 2005 Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet 365:2014-2023.
4. Black P, Straaten A, Gutjahr P 1998 Secondary thyroid carcinoma after treatment for childhood cancer. Med Pediatr Oncol 31:91-95.
5. Gow KW, Lensing S, Hill DA, Krasin MJ, McCarville MB, Rai SN, Zacher M, Spunt SL, Strickland DK, Hudson MM 2003 Thyroid carcinoma presenting inchildhoodor after treatment of childhood malignancies: an institutional experience and review of the literature. J Pediatr Surg 38:1574-1580.
6. Cohen A, Rovelli A, van Lint MT, Merlo F, Gaiero A, Mulas R, Balduzzi A, Corti P, Uderzo C, Bacigalupo A 2001 Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood. Bone Marrow Transplant 28:1125-1128.
7. Mahoney MC, Lawvere S, Falkner KL, Averkin YI, Ostapenko VA, Michalek AM, Moysich KB, McCarthy PL 2004 Thyroid cancer incidence trends in Belarus: examining the impact of Chernobyl. Int J Epidemiol 33:1025-1033.
8. Ron E 2007 Thyroid cancer incidence among people living in areas contaminated by radiation from the Chernobyl accident. Health Phys 93:502-511.
9. Stsjazhko VA, Tsyb AF, Tronko ND, Souchkevitch G, Baverstock KF 1995 Childhood thyroid cancer since accident at Chernobyl. BMJ 310:801.
10. Cardis E, Howe G, Ron E, Bebeshko V, Bogdanova T, Bouville A, Carr Z, Chumak V, Davis S, Demidchik Y, Drozdovitch V, Gentner N, Gudzenko N, Hatch M, Ivanov V, Jacob P, Kapitonova E, Kenigsberg Y, Kesminiene A, Kopecky KJ, Kryuchkov V, Loos A, Pinchera A, Reiners C, Repacholi M, Shibata Y, Shore RE, Thomas G, Tirmarche M, Yamashita S, Zvonova I 2006 Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot 26:127-140. (Pubitemid 43861071)
11. Farahati J, Demidchik EP, Biko J, Reiners C 2000 Inverse association between age at the time of radiation exposure and extent of disease in cases of radiation-induced childhood thyroid carcinoma in Belarus. Cancer 88:1470-1476.
12. Thomas GA, Bunnell H, Cook HA, Williams ED, Nerovnya A, Cherstvoy ED, Tronko ND, Bogdanova TI, Chiappetta G, Viglietto G, Pentimalli F, Salvatore G, Fusco A, Santoro M, Vecchio G 1999 High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab 84:4232-4238.
13. Nikiforov YE, Koshoffer A, Nikiforova M, Stringer J, Fagin JA 1999 Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid carcinomas. Oncogene 18:6330-6334.
14. Nakashima M, Takamura N, Namba H, Saenko V, Meirmanov S, Matsumoto N, Hayashi T, Maeda S, Sekine I 2007 RET oncogene amplification in thyroid cancer: correlations with radiation-associated and high-grade malignancy. Hum Pathol 38:621-628.
15. Richter H, Braselmann H, Hieber L, Thomas G, Bogdanova T, Tronko N, Zitzelsberger H 2004 Chromosomal imbalances in post-Chernobyl thyroid tumors. Thyroid 14:1061-1064.
16. Hemmer S, Wasenius VM, Knuutila S, Franssila K, Joensuu H 1999 DNA copy number changes in thyroid carcinoma. Am J Pathol 154:1539-1547. (Pubitemid 29226448)
17. Singh B, Lim D, Cigudosa JC, Ghossein R, Shaha AR, Poluri A, Wreesmann VB, Tuttle M, Shah JP, Rao PH 2000 Screening for genetic aberrations in papillary thyroid cancer by using comparative genomic hybridization. Surgery 128:888-893.
18. Roque L, Nunes VM, Ribeiro C, Martins C, Soares J 2001 Karyotypic characterization of papillary thyroid carcinomas. Cancer 92:2529-2538.
19. Bauer AJ, Cavalli LR, Rone JD, Francis GL, Burch HB, Tuttle RM, Ringel MD, Stratakis CA, Haddad BR 2002 Evaluation of adult papillary thyroid carcinomas by comparative genomic hybridization and microsatellite instability analysis. Cancer Genet Cytogenet 135:182-186.
20. Finn S, Smyth P, O'Regan E, Cahill S, Toner M, Timon C, Flavin R, O'Leary J, Sheils O 2007 Low-level genomic instability is a feature of papillary thyroid carcinoma: an array comparative genomic hybridization study of laser capture microdissected papillary thyroid carcinoma tumors and clonal cell lines. Arch Pathol Lab Med 131:65-73.
21. Unger K, Malisch E, Thomas G, Braselmann H, Walch A, Jackl G, Lewis P, Lengfelder E, Bogdanova T, Wienberg J, Zitzelsberger H 2008 Array CGH demonstrates characteristic aberration signatures in human papillary thyroid carcinomas governed by RET/PTC. Oncogene 27:4592-4602.
22. Lo KC, Stein LC, Panzarella JA, Cowell JK, Hawthorn L 2008 Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis. Lung Cancer 59:315-331.
23. Yeung KY, Ruzzo WL 2001 Principal component analysis for clustering gene expression data. Bioinformatics 17:763-774.
24. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM, de la CA 2005 The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 102:19075-19080.
25. Lo KC, Bailey D, Burkhardt T, Gardina P, Turpaz Y, Cowell JK 2008 Comprehensive analysis of loss of heterozygosity events in glioblastoma using the 100K SNP mapping arrays and comparison with copy number abnormalities defined by BAC array comparative genomic hybridization. Genes Chromosomes Cancer 47:221-237.
26. Ward LS, Brenta G, Medvedovic M, Fagin JA 1998 Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas. J Clin Endocrinol Metab 83:525-530.
27. Eisen MB, Spellman PT, Brown PO, Botstein D 1998 Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95:14863-14868.
28. Lo KC, Rossi MR, LaDuca J, Hicks DG, Turpaz Y, Hawthorn L, Cowell JK 2007 Candidate glioblastoma development gene identification using concordance between copy number abnormalities and gene expression level changes. Genes Chromosomes Cancer 46:875-894.
29. Lo KC, Rossi MR, Burkhardt T, Pomeroy SL, Cowell JK 2007 Overlay analysis of the oligonucleotide array gene expression profiles and copy number abnormalities as determined by array comparative genomic hybridization in medulloblastomas. Genes Chromosomes Cancer 46:53-66.
30. Gardina PJ, Lo KC, Lee W, Cowell JK, Turpaz Y 2008 Ploidy status and copy number aberrations in primary glioblastomas defined by integrated analysis of allelic ratios, signal ratios and loss of heterozygosity using 500K SNP Mapping Arrays. BMC Genomics 9:489.
31. Chen X, Knauf JA, Gonsky R, Wang M, Lai EH, Chissoe S, Fagin JA, Korenberg JR 1998 From amplification to gene in thyroid cancer: a high-resolution mapped bacterial-artificialchromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization. Am J Hum Genet 63:625-637.
32. Wreesmann VB, Sieczka EM, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Patel KN, Tallini G, Prystowsky M, Shaha AR, Kraus D, Shah JP, Rao PH, Ghossein R, Singh B 2004 Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker. Cancer Res 64:3780-3789.
33. Rodrigues R, Roque L, Espadinha C, Pinto A, Domingues R, Dinis J, Catarino A, Pereira T, Leite V 2007 Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array analysis in aneuploid papillary thyroid carcinomas. Oncol Rep 18:917-926.
34. Kjellman P, Lagercrantz S, Hoog A, Wallin G, Larsson C, Zedenius J 2001 Gain of 1q and loss of 9q21.3-q32 are associated with a less favorable prognosis in papillary thyroid carcinoma. Genes Chromosomes Cancer 32:43-49.
35. Chen GG, Vlantis AC, Zeng Q, van Hasselt CA 2008 Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer. Curr Cancer Drug Targets 8:367-377.
36. Umbricht CB, Conrad GT, Clark DP, Westra WH, Smith DC, Zahurak M, Saji M, Smallridge RC, Goodman S, Zeiger MA 2004 Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumors. Clin Cancer Res 17:5762-5768.
37. Detours V, Wattel S, Venet D, Hutsebaut N, Bogdanova T, Tronko MD, Dumont JE, Franc B, Thomas G, Maenhaut C 2005 Absence of a specific radiation signature in post-Chernobyl thyroid cancers. Br J Cancer 92:1545-1552.
38. Detours V, Delys L, Libert F, Weiss SD, Bogdanova T, Dumont JE, Franc B, Thomas G, Maenhaut C 2007 Genomewide gene expression profiling suggests distinct radiation susceptibilities in sporadic and post-Chernobyl papillary thyroid cancers. Br J Cancer 97:818-825.
39. Port M, Boltze C, Wang Y, Roper B, Meineke V, Abend M 2007 A radiation-induced gene signature distinguishes post-Chernobyl from sporadic papillary thyroid cancers. Radiat Res 168:639-649.
40. Jarzab B, Wiench M, Fujarewicz K, Simek K, Jarzab M, Oczko-Wojciechowska M, Wloch J, Czarniecka A, Chmielik E, Lange D, Pawlaczek A, Szpak S, Gubala E, Swierniak A 2005 Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. Cancer Res 65:1587-1597.
41. Hawthorn L, Stein L, Varma R, Wiseman S, Loree T, Tan D 2004 TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma. Head Neck 26:1069-1083.
42. Huang Y, Prasad M, Lemon WJ, Hampel H, Wright FA, Kornacker K, LiVolsi V, Frankel W, Kloos RT, Eng C, Pellegata NS, de la CA 2001 Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci U S A 98:15044-15049.
43. Murphy KM, Chen F, Clark DP 2008 Identification of immunohistochemical biomarkers for papillary thyroid carcinoma using gene expression profiling. Hum Pathol 39:420-426.
44. Griffith OL, Melck A, Jones SJ, Wiseman SM 2006 Metaanalysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J Clin Oncol 24:5043-5051.
45. Eszlinger M, Wiench M, Jarzab B, Krohn K, Beck M, Lauter J, Gubala E, Fujarewicz K, Swierniak A, Paschke R 2006 Metaand reanalysis of gene expression profiles of hot and cold thyroid nodules and papillary thyroid carcinoma for gene groups. J Clin Endocrinol Metab 91:1934-1942.
46. Fontaine JF, Mirebeau-Prunier D, Franc B, Triau S, Rodien P, Houlgatte R, Malthiery Y, Savagner F 2008 Microarray analysis refines classification of non-medullary thyroid tumours of uncertain malignancy. Oncogene 27:2228-2236.
47. Durand S, Ferraro-Peyret C, Selmi-Ruby S, Paulin C, El Atifi M, Berger F, Berger-Dutrieux N, Decaussin M, Peix JL, Bournaud C, Orgiazzi J, Borson-Chazot F, Rousset B 2008 Evaluation of gene expression profiles in thyroid nodule biopsy material to diagnose thyroid cancer. J Clin Endocrinol Metab 93:1195-1202.
48. Oler G, Camacho CP, Hojaij FC, Michaluart P Jr, Riggins GJ, Cerutti JM 2008 Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis. Clin Cancer Res 14:4735-4742.
49. Delys L, Detours V, Franc B, Thomas G, Bogdanova T, Tronko M, Libert F, Dumont JE, Maenhaut C 2007 Gene expression and the biological phenotype of papillary thyroid carcinomas. Oncogene 26:7894-7903.
50. Fujarewicz K, Jarzab M, Eszlinger M, Krohn K, Paschke R, Oczko-Wojciechowska M, Wiench M, Kukulska A, Jarzab B, Swierniak A 2007 A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping. Endocr Relat Cancer 14:809-826.
51. Wang Y, Zhang M, Middleton FA, Horton JA, Pritchard M, Spadaro JA, Farnum CE, Damron TA 2007 Connective tissue growth factor and insulin-like growth factor 2 show upregulation in early growth plate radiorecovery response following irradiation. Cells Tissues Organs 186:192-203.
52. Dazard JE, Gal H, Amariglio N, Rechavi G, Domany E, Givol D 2003 Genome-wide comparison of human keratinocyte and squamous cell carcinoma responses to UVB irradiation: implications for skin and epithelial cancer. Oncogene 22:2993-3006.
53. Kis E, Szatmari T, Keszei M, Farkas R, Esik O, Lumniczky K, Falus A, Safrany G 2006 Microarray analysis of radiation response genes in primary human fibroblasts. Int J Radiat Oncol Biol Phys 66:1506-1514.
54. Rosen CF, Poon R, Drucker DJ 1995 UVB radiation-activated genes induced by transcriptional and posttranscriptional mechanisms in rat keratinocytes. Am J Physiol 268: C846-C855.
55. Bo H, Ghazizadeh M, Shimizu H, Kurihara Y, Egawa S, Moriyama Y, Tajiri T, Kawanami O 2004 Effect of ionizing irradiation on human esophageal cancer cell lines by cDNA microarray gene expression analysis. J Nippon Med Sch 71:172-180.
56. Koike M, Ninomiya Y, Koike A 2008 Characterization of Ninjurin and TSC22 induction after X-irradiation of normal human skin cells. J Dermatol 35:6-17.
57. Park HJ, Choi EK, Choi J, Ahn KJ, Kim EJ, Ji IM, Kook YH, Ahn SD, Williams B, Griffin R, Boothman DA, Lee CK, Song CW 2005 Heat-induced up-regulation of NAD (P) H: quinone oxidoreductase potentiates anticancer effects of betalapachone. Clin Cancer Res 11:8866-8871.
58. Suzuki M, Amano M, Choi J, Park HJ, Williams BW, Ono K, Song CW 2006 Synergistic effects of radiation and betalapachone in DU-145 human prostate cancer cells in vitro. Radiat Res 165:525-531.
59. Choi EK, Terai K, Ji IM, Kook YH, Park KH, Oh ET, Griffin RJ, Lim BU, Kim JS, Lee DS, Boothman DA, Loren M, Song CW, Park HJ 2007 Upregulation of NAD (P) H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells. Neoplasia 9:634-642.